0.109
price up icon12.84%   0.0124
after-market アフターアワーズ: .11 0.001 +0.92%
loading

Spruce Biosciences Inc (SPRB) 最新ニュース

pulisher
Jul 27, 2025

Spruce Biosciences (NASDAQ:SPRB) Shares to Reverse Split on Monday, August 4th - Defense World

Jul 27, 2025
pulisher
Jul 25, 2025

Spruce Biosciences Announces Reverse Stock Split Plan - The Globe and Mail

Jul 25, 2025
pulisher
Jul 25, 2025

Spruce Biosciences to enact 1-for-75 reverse stock split - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Spruce Biosciences to implement 1-for-75 reverse stock split - Investing.com

Jul 25, 2025
pulisher
Jul 24, 2025

Spruce Biosciences Announces Reverse Stock Split - Business Wire

Jul 24, 2025
pulisher
Jul 22, 2025

HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Spruce Biosciences (SPRB) Advances in Phase 2 Depression Treatme - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

Spruce Biosciences (NASDAQ:SPRB) Trading Up 5.7% – Here’s What Happened - Defense World

Jul 22, 2025
pulisher
Jul 18, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 18, 2025
pulisher
Jul 14, 2025

Ultragenyx hit again, this time with a CRL in rare disease - BioWorld MedTech

Jul 14, 2025
pulisher
Jul 14, 2025

Spruce Biosciences (SPRB) Gains Investor Attention with Significant Interest Surge | SPRB Stock News - GuruFocus

Jul 14, 2025
pulisher
Jul 07, 2025

Spruce Biosciences gets conditional approval to resume trading on Nasdaq Capital Market - MSN

Jul 07, 2025
pulisher
Jul 05, 2025

Spruce Biosciences (NASDAQ:SPRB) versus Pharmaxis (OTCMKTS:PXSLY) Head-To-Head Analysis - Defense World

Jul 05, 2025
pulisher
Jul 03, 2025

Congenital Adrenal Hyperplasia Treatment Market Outlook Influenced by Gene Therapy Innovations 2025 - openPR.com

Jul 03, 2025
pulisher
Jul 02, 2025

SPRB ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Spruce Biosciences, Inc. - ACCESS Newswire

Jul 02, 2025
pulisher
Jul 01, 2025

BriaCell Therapeutics (OTCMKTS:BCTXF) vs. Spruce Biosciences (NASDAQ:SPRB) Head-To-Head Survey - Defense World

Jul 01, 2025
pulisher
Jun 25, 2025

Congenital Adrenal Hyperplasia Pipeline Insight, 2025: - openPR.com

Jun 25, 2025
pulisher
Jun 13, 2025

Spruce Biosciences (SPRB) Secures Nasdaq Approval for Relisting - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Spruce Biosciences Announces Conditional Nasdaq Approval to Resu - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

# Spruce Biosciences to resume Nasdaq trading pending stock split approval By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market - BioSpace

Jun 12, 2025
pulisher
Jun 12, 2025

Spruce Biosciences regains Nasdaq compliance path By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Spruce Biosciences regains Nasdaq compliance path - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

# Spruce Biosciences to resume Nasdaq trading pending stock split approval - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Spruce Biosciences’ Compliance Plan Accepted by Nasdaq - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market | SPRB Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 10, 2025

Neurocrine Loses Suit Challenging Hormone Treatment Patent - Law360

Jun 10, 2025
pulisher
Jun 10, 2025

Judge Tosses Neurocrine’s Suit Over Spruce Hormone-Drug Patent - Bloomberg Law News

Jun 10, 2025
pulisher
Jun 05, 2025

Congenital Adrenal Hyperplasia Market Growth Projections - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Berkshire Near All-time Highs: Could This Be Buffett's Final Defining Act? - The Globe and Mail

Jun 05, 2025
pulisher
Jun 05, 2025

Time to Buy These 3 Cheap Stocks? - The Globe and Mail

Jun 05, 2025
pulisher
Jun 05, 2025

If I Could Only Buy and Hold a Single Stock, This Would Be It - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Is Chipotle Mexican Grill Stock Underperforming the S&P 500? - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Is Palo Alto Networks Stock Outperforming the S&P 500? - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Is Amphenol Stock Outperforming the Dow? - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

What Nvidia, AMD, and CoreWeave Stock Investors Should Know About the Recent AI Training Benchmark - The Globe and Mail

Jun 04, 2025
pulisher
May 29, 2025

Spruce Biosciences Enters Purchase Agreement with Board Chair - TipRanks

May 29, 2025
pulisher
May 27, 2025

Top 100 Stocks to Buy: Is Amer Sports Stock Ready to Head Downhill? - The Globe and Mail

May 27, 2025
pulisher
May 11, 2025

FY2025 EPS Estimates for OTCMKTS:GTBIF Reduced by Analyst - Defense World

May 11, 2025
pulisher
May 11, 2025

Axalta Coating Systems (NYSE:AXTA) Price Target Raised to $40.00 - Defense World

May 11, 2025
pulisher
May 11, 2025

FY2025 EPS Estimates for InnovAge Decreased by William Blair - Defense World

May 11, 2025
pulisher
May 11, 2025

Guggenheim Forecasts Strong Price Appreciation for Wingstop (NASDAQ:WING) Stock - Defense World

May 11, 2025
pulisher
May 10, 2025

What is Seaport Res Ptn’s Forecast for FWONA Q3 Earnings? - Defense World

May 10, 2025
pulisher
May 10, 2025

Spruce Biosciences (SPRB) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 10, 2025

Leerink Partnrs Issues Positive Outlook for SPRB Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Spruce Biosciences, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Spruce Biosciences (SPRB) - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

'It's a mess out there': More biotech layoffs mean stiff competition for jobs at emerging companies - The Business Journals

May 09, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Reduces Stock Holdings in Spruce Biosciences, Inc. (NASDAQ:SPRB) - Defense World

May 07, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):